Scilex Holding Company Increase (Decrease) in Prepaid Expenses, Other
Scilex Holding Company (SCLX) reported Increase (Decrease) in Prepaid Expenses, Other of $1.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpensesOther · last filed 2026-08-14
- Scilex Holding Company increase (decrease) in prepaid expenses, other for the quarter ending 2026-06-30 was $1.61M.
- Scilex Holding Company increase (decrease) in prepaid expenses, other for the quarter ending 2026-03-31 was -$614.00K.
- Scilex Holding Company increase (decrease) in prepaid expenses, other for the quarter ending 2025-12-31 was $3.52M.
- Scilex Holding Company increase (decrease) in prepaid expenses, other for the quarter ending 2025-09-30 was -$5.36M, a 260.82% decline year-over-year.
- Scilex Holding Company increase (decrease) in prepaid expenses, other for fiscal 2025 was -$3.30M, a 788.94% decline from fiscal 2024.
- Scilex Holding Company increase (decrease) in prepaid expenses, other for fiscal 2024 was $479.00K, a 8.62% increase from fiscal 2023.
- Scilex Holding Company increase (decrease) in prepaid expenses, other for fiscal 2023 was $441.00K, a 83.23% decline from fiscal 2022.
- Scilex Holding Company increase (decrease) in prepaid expenses, other for fiscal 2022 was $2.63M.
| Period end | Increase (Decrease) in Prepaid Expenses, Other 3 month | Increase (Decrease) in Prepaid Expenses, Other 6 month | Increase (Decrease) in Prepaid Expenses, Other 6 month as first filed | Increase (Decrease) in Prepaid Expenses, Other 9 month | Increase (Decrease) in Prepaid Expenses, Other 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $1.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $1.00M 10-Q · filed 2026-08-14 | $4.52M derived: sum of 3 quarters · filed 2026-08-14 | -$834.00K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | -$614.00K 10-Q · filed 2026-05-20 | $2.91M derived: sum of 2 quarters · filed 2026-05-20 | -$2.45M derived: sum of 3 quarters · filed 2026-05-20 | -$3.79M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-12-31 | $3.52M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-10 | -$1.83M derived: sum of 2 quarters · filed 2026-04-10 | -$3.17M derived: sum of 3 quarters · filed 2026-08-14 | -$3.30M 10-K · filed 2026-04-10 | |
| 2025-09-30 | -$5.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$6.69M derived: sum of 2 quarters · filed 2026-08-14 | -$6.82M 10-Q · filed 2025-11-14 | -$9.20M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-06-30 | -$1.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$1.47M 10-Q · filed 2026-08-14 | -$3.84M derived: sum of 3 quarters · filed 2026-08-14 | -$513.00K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | -$129.00K 10-Q · filed 2026-05-20 | -$2.51M derived: sum of 2 quarters · filed 2026-05-20 | $824.00K derived: sum of 3 quarters · filed 2026-05-20 | $311.00K derived: sum of 4 quarters · filed 2026-05-20 | |
| 2024-12-31 | -$2.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-10 | $953.00K derived: sum of 2 quarters · filed 2026-04-10 | $440.00K derived: sum of 3 quarters · filed 2026-04-10 | $479.00K 10-K · filed 2026-04-10 | |
| 2024-09-30 | $3.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $2.82M derived: sum of 2 quarters · filed 2025-11-14 | $2.86M 10-Q · filed 2025-11-14 | $4.37M derived: sum of 4 quarters · filed 2025-11-14 | |
| 2024-06-30 | -$513.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$474.00K 10-Q · filed 2025-08-13 | $1.04M derived: sum of 3 quarters · filed 2025-08-13 | -$42.00K derived: sum of 4 quarters · filed 2025-08-13 | |
| 2024-03-31 | $39.00K 10-Q · filed 2025-05-14 | $1.55M derived: sum of 2 quarters · filed 2025-05-14 | $471.00K derived: sum of 3 quarters · filed 2025-05-14 | $774.00K derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | $1.51M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $432.00K derived: sum of 2 quarters · filed 2025-03-31 | $735.00K derived: sum of 3 quarters · filed 2025-03-31 | $441.00K 10-K · filed 2025-03-31 | |
| 2023-09-30 | -$1.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-01-17 | -$778.00K derived: sum of 2 quarters · filed 2025-01-17 | -$1.07M 10-Q · filed 2025-01-17 | -$1.92M derived: sum of 4 quarters · filed 2025-01-17 | |
| 2023-06-30 | $303.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $9.00K 10-Q · filed 2024-08-13 | -$9.00K 10-Q · filed 2023-08-11 | -$840.00K derived: sum of 3 quarters · filed 2024-08-13 | $1.05M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | -$294.00K 10-Q · filed 2024-05-13 | -$1.14M derived: sum of 2 quarters · filed 2024-05-13 | $750.00K derived: sum of 3 quarters · filed 2024-05-13 | -$989.00K derived: sum of 4 quarters · filed 2024-05-13 | |
| 2022-12-31 | -$849.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $1.04M derived: sum of 2 quarters · filed 2024-03-12 | -$695.00K derived: sum of 3 quarters · filed 2024-03-12 | $2.63M 10-K · filed 2024-03-12 | |
| 2022-09-30 | $1.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $154.00K derived: sum of 2 quarters · filed 2023-11-14 | $3.48M 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | -$1.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $1.58M 10-Q · filed 2023-08-11 | |||
| 2022-03-31 | $3.32M 10-Q · filed 2023-05-12 | ||||
| 2021-12-31 | -$1.48M 10-K · filed 2024-03-12 | ||||
| 2020-12-31 | $1.03M 10-K · filed 2023-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |